Resources

Depression

icon

A Randomized Placebo-Controlled Pet Study of Ketamine’s Effect on Serotonin1B Receptor Binding in Patients With SSRI-Resistant Depression

Translational Psychiatry | June 2020

icon

Comprehensive Assessment of Side Effects Associated With a Single Dose of Ketamine in Treatment-Resistant Depression

Journal of Affective Disorders | November 2019

icon

Intravenous Ketamine for Adolescents With Treatment-Resistant Depression: An Open-Label Study

Journal of Child and Adolescent Psychopharmacology | July 2018

icon

Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial

American Journal of Psychiatry | December 2017

icon

World-First Ketamine Trial Shows Promise for Geriatric Depression

American Journal of Geriatric Psychiatry | July 2017

icon

FDA Data Support Ketamine as Depression Therapy

MedPage Today | May 2017

icon

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

Am J Psychiatry | October 2013

icon

Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression

Biological Psychiatry | August 2013

icon

Serial Infusions of Low-Dose Ketamine for Major Depression

Journal of Psychopharmacology | May 2013

icon

Ketamine as a Novel Antidepressant: From Synapse to Behavior

Clinical Pharmacology & Therapeutics | December 2011

Anxiety

icon

Effects of Ketamine in Patients With Treatment-Refractory Generalized Anxiety and Social Anxiety Disorders

Journal of Psychopharmacology | Sept 2019

icon

Safety and Efficacy of Maintenance Ketamine Treatment in Patients With Treatment-Refractory Generalized Anxiety and Social Anxiety Disorders

Journal of Psychopharmacology | March 2018

icon

Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial

Neuropsychopharmacology | Jan 2018

icon

Ketamine’s Dose-Related Effects on Anxiety Symptoms in Patients With Treatment-Refractory Anxiety Disorders

Journal of Psychopharmacology | April 2017

PTSD | Ketamine & SGB

icon

Effect of SGB Treatment on PTSD

JAMA | November 2019

icon

New Promise for Treating PTSD

Psychology Today | August 2019

icon

Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder: A Randomized Clinical Trial

JAMA Psychiatry | June 2014

icon

Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression

J Clin Psychiatry | May/June 2018

icon

Ketamine As Treatment For Post-Traumatic Stress Disorder: A Review

NIH | April 2019

Chronic Pain | Migraines, CRPS, Neuropathy

icon

The Use of Ketamine Infusions for Refractory Headaches: A Retrospective Analysis

Am Society of Anesthesiologists | October 2017

icon

Multi-Day Low Dose Ketamine Infusion for the Treatment of Complex Regional Pain Syndrome

Pain Physician | April 2005

icon

Subanesthetic Ketamine Infusion Therapy: A Retrospective Analysis of a Novel Therapeutic Approach to Complex Regional Pain Syndrome

Pain Medicine | September 2004

Other

icon

Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-Of-Concept

Neuropsychopharmacology | November 2013